A low postmortem blood methanol result did not reliably represent the brain findings in two treated fatalities. In a three-case report, investigators found much higher brain methanol concentrations after hospital treatment than the corresponding autopsy blood results suggested. The observation supports attention to treatment history and specimen selection; it does not establish a universal brain-to-blood conversion.
Three linked exposures, different survival and treatment
Andresen and colleagues described three men, aged 39, 34 and 44, linked by an investigation of shared methanol ingestion. The first two were admitted to hospital in coma with severe metabolic acidosis. Initial serum methanol concentrations were 5,400 and 7,400 mg/L. Both received ethanol, folic acid, bicarbonate and hemodialysis after detection of the poisoning.
They died four and three days after admission, respectively. The third man was found dead without the hospital treatment described for the other two. This was a descriptive case series with one person in each clinical course, not a randomized comparison of dialysis or a controlled experiment isolating redistribution.
Autopsy measurements differed by tissue
| Specimen and units | Case 1 | Case 2 | Case 3 |
|---|---|---|---|
| Femoral venous blood, mg/L | 5* | 228 | 2,074 |
| Cardiac blood, mg/L | 5* | 254 | 2,130 |
| Vitreous humor, mg/L | 8* | 201 | 2,122 |
| Brain stem, mg/kg | 738 | 1,008 | 2,213 |
| Cerebellum, mg/kg | 1,828 | Not available | 1,811 |
*The paper reports these numbers, but its stated blood detection limit was 15 mg/L and quantitation limit 53 mg/L. The values of 5 and 8 cannot be represented as validated quantitative measurements within those stated limits; the method was validated in serum, with additional uncertainty about performance in other matrices.
Table 2 supplies the 228 mg/L femoral result for case 2; the earlier clinical-course table rounds or reports it as 220 mg/L. Keeping the chosen table and its units explicit avoids creating an apparently exact agreement that the source does not provide.
The untreated case had broadly similar numerical concentrations across several fluids and tissues, while the treated cases showed larger brain–blood differences. Fluid results in mg/L and tissue results in mg/kg should retain their distinct units. The numbers are not evidence that the same conversion applies across brain regions, treatment courses or other deaths.
Collection and analytical performance matter
Autopsy specimens included femoral and cardiac blood, vitreous, urine, cerebrospinal fluid and tissues. Aliquots were placed in capped, sealed glass vials and stored at 4°C for up to 14 days before analysis. The paper does not provide a standardized individual death-to-autopsy interval for every comparison or a storage experiment proving unchanged concentrations across that period.
Methanol and ethanol were measured by headspace gas chromatography with flame-ionization detection, using tertiary butanol as internal standard. This was targeted chromatographic analysis, not an immunoassay or mass-spectrometric drug screen. The serum-validated method used an eight-point daily calibration, reported linearity up to 5,000 mg/L with R² = 0.996, and specified repeat analysis after dilution for initial results above 5,000 mg/L.
Serum validation does not establish equivalent accuracy, recovery or sensitivity in every brain and postmortem fluid specimen. The published low numbers and validation scope are material limits, even though the overall contrast between the reported brain and blood findings prompted the authors’ specimen-selection concern.
Why did brain and blood differ?
The investigators proposed explanations including impaired clearance from brain tissue associated with edema and disturbed blood flow. They also discussed tissue distribution. These were hypotheses; the study did not directly measure cerebral perfusion or experimentally assign the difference to one mechanism.
Hospital treatment had already changed the measured blood course before death. Comparing an initial serum value with later autopsy whole blood therefore combines treatment, elapsed time, different matrices and possible postmortem processes. It does not measure an isolated postmortem redistribution factor.
What can a death investigation conclude?
The authors recommended considering brain methanol testing alongside blood in suspected fatalities with longer survival. Their three cases support that focused concern, especially when earlier clinical evidence documents severe poisoning. They do not show that every low blood result conceals a high brain concentration.
The report also described neuropathological injury, but did not establish a universally diagnostic lesion or a concentration-only rule for causation. It cannot supply contemporary brain-death determination standards, a clinical treatment protocol or an impairment threshold. Related specimen and timing issues appear in the comparison of earlier serum with postmortem chloroquine blood.
Primary source
Andresen H, Schmoldt H, Matschke J, Flachskampf FA, Turk EE. Fatal methanol intoxication with different survival times—Morphological findings and postmortem methanol distribution. Forensic Science International. 2008;179:206–210. doi:10.1016/j.forsciint.2008.05.014.
Leave a Reply